About Medicure

Our Company

Medicure is a pharmaceutical company focused on the development and commercialization of innovative and affordable therapeutics for the U.S. market. Medicure's sales force markets to physicians and other healthcare professionals and with E-Commerce integration offering patients and providers direct online ordering and home delivery. Our vision is to become a leading pharmaceutical company within the U.S., offering a growing portfolio of products that improve patients' lives.

Medicure Inc. Corporate Information

Medicure Inc. is publicly traded on the Toronto Stock Exchange Venture under the symbol "MPH". Its subsidiaries include Medicure International, Inc. (Barbados), which owns the U.S. rights to AGGRASTAT, as well as two U.S. corporations, Medicure USA, Inc. and Medicure Pharma, Inc., which distributes the Company's products in the United States.

For more information About Medicure and the risks and uncertainties involved in its business, please refer to the most recent Management Discussion and Analysis and in the "Risk Factors" section of its most recent Form 20F.

Contact Information

Investor Relations
ir@medicure.com